Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-10

Clinical Trial Update: Botulinum Neurotoxin for Children With CP: a Delicate Balance Between Clinical Benefits and Muscular Harm

View source ↗

Summary

A clinical trial is evaluating Botulinum Neurotoxin in children with spastic cerebral palsy, balancing potential clinical benefits with the risk of muscular har…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum Neurotoxin (botulinum toxin)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Spastic Cerebral Palsy (sCP) | Status: RECRUITING